ASX
Prescient Therapeutics Limited
PTX:ASX•Healthcare
Sensitive ASX Announcement
US Patent Granted for PTX-200 for Ovarian Cancer Treatment
Published: 26/07/18, 08:58am (AEST)•3 pages